MedTrace Logo

Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)

NCT07185828 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8286

Last updated 2026-03-13

No results posted yet for this study

Summary

The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED). In this campaign, patients will be assigned to receive or not receive outreach following ED discharge with a low-acuity visit designation. Outreach will occur via a text message the day after discharge from the ED as well as information added to the patient's after visit summary (AVS). Depending on the assigned condition, it will include calls to see their primary care provider (PCP) or use an Intelligent Triage tool. The study will assess whether ED use within the following 120 days differs across patients in different outreach conditions (current standard practice vs contact your PCP vs use Intelligent Triage). It will also examine whether patients follow through on the message-specific calls to action differently across conditions.

Conditions

  • Emergency Service, Hospital
  • Behavior Change Interventions

Interventions

BEHAVIORAL

Contact your PCP

Text messages will be sent and discharge paperwork will be modified to encourage contacting a primary care provider.

BEHAVIORAL

Use Intelligent Triage

Text messages will be sent and discharge paperwork will be modified to encourage using Intelligent Triage.

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Amir Goren, PhD · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2026-05-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07185828 on ClinicalTrials.gov